Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

NCT00982488 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

238

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Dasatinib
DRUG: Imatinib

Sponsor

Bristol-Myers Squibb